Jun Lei
Wuhan University
9 Papers
8 Citations
Jun Lei is an academic researcher from Wuhan University. The author has contributed to research in topics: Medicine & Indocyanine green. The author has an hindex of 3, co-authored 5 publications.
Chat about Author
Papers
Diagnostic and Management Options of Osteoblastoma in the Spine.
TL;DR: Accurate intraoperative localization with complete resection is the key to preventing recurrence and Aggressive surgical resection can achieve satisfactory clinical and radiographic outcomes.
Biphasic Injectable Bone Cement with Fe3O4/GO Nanocomposites for the Minimally Invasive Treatment of Tumor-Induced Bone Destruction.
TL;DR: This study doped Fe3O4/graphene oxide (GO) nanocomposites into α-tricalcium phosphate (α-TCP)/calcium sulfate (CS) biphasic bone cement to prepare an injectable magnetic bone cement, which can be applied in bone tumor minimally invasive surgery and fit ideally even if the area is irregular.
29
Lumbopelvic Fixation and Sacral Decompression for U-shaped Sacral Fractures: Surgical Management and Early Outcome.
Yuanlong Xie,Lin Cai,Ansong Ping,Jun Lei,Zhouming Deng,Chao Hu,Xiao-Bing Zhu +6 more
- 01 Aug 2018
TL;DR: Lumbopelvic fixation is an effective method for stabilization of U-shaped sacral fractures with fewer complications developed and effective reduction and firm fixation are the prerequisite of early mobilization and neurological recovery.
15
The minimally invasive endoscopic technique for the treatment of symptomatic benign bone lesions: Preliminary results from a retrospective study.
TL;DR: The procedure described may be a valuable alternative to open surgery for symptomatic benign bone lesions and report significant improvements in pain, quality of life and functional recovery without complications or need for secondary interventions.
12
Effects of Andersson lesion treatment in ankylosing spondylitis: A medical record review study focused on medium‐ to long‐term outcomes
TL;DR: Surgery remains the optimal treatment for AL in ankylosing spondylitis patients, with better clinical efficacy demonstrated by medium‐ to long‐term follow‐up data.
10